1. Introductory paper: High-dose influenza vaccine
- Author
-
Corey A Robertson, Monica Mercer, David P. Greenberg, Ayman Chit, Sandrine I. Samson, Bruce T. Seet, Mia Diaco, Rosalind Hollingsworth, and Lee-Jah Chang
- Subjects
medicine.medical_specialty ,Influenza vaccine ,030231 tropical medicine ,Global Health ,Seasonal influenza ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,Influenza, Human ,medicine ,Humans ,030212 general & internal medicine ,Healthy aging ,Aged ,Supplementary data ,General Veterinary ,General Immunology and Microbiology ,business.industry ,Public health ,Vaccination ,Public Health, Environmental and Occupational Health ,virus diseases ,Quality of evidence ,Infectious Diseases ,Influenza Vaccines ,Molecular Medicine ,Seasons ,business - Abstract
Seasonal influenza has a significant impact on global public health each year, especially in older adults 65 years of age and above. This paper presents the evolution of high-dose influenza vaccine and the quantity as well as quality of evidence on this vaccine. Its introduces other peer-reviewed manuscripts included in this supplement covering the benefits high-dose influenza vaccine over ten consecutive influenza seasons. The development of the high-dose influenza vaccine represents an important step in the evolution of influenza vaccines, offering an advancement in prevention of influenza and a step in encouraging healthy aging in older adults. A video summary of the article can be accessed via the Supplementary data link at the end of this article.
- Published
- 2020